Biotechnological Valorization of Food Marine Wastes: Microbial Productions on Peptones Obtained from Aquaculture By-Products

© 2020 by the authors. Based on a biotechnological strategy, in the present work several peptones are produced from the Alcalase hydrolysis (0.1–0.2% v/w, 56–64 °C, pH 8.27–8.98, 3 h) and thermal processing (105 °C, 60 min) of wastes generated from the industrial processing of turbot, salmon, trout,...

Full description

Bibliographic Details
Published in:Biomolecules
Main Authors: Vázquez, José Antonio, Durán, Ana, Menduiña, Araceli, Nogueira, Margarita
Other Authors: Xunta de Galicia, European Commission
Format: Article in Journal/Newspaper
Language:English
Published: Multidisciplinary Digital Publishing Institute 2020
Subjects:
Online Access:http://hdl.handle.net/10261/218413
https://doi.org/10.3390/biom10081184
https://doi.org/10.13039/501100000780
https://doi.org/10.13039/501100010801
Description
Summary:© 2020 by the authors. Based on a biotechnological strategy, in the present work several peptones are produced from the Alcalase hydrolysis (0.1–0.2% v/w, 56–64 °C, pH 8.27–8.98, 3 h) and thermal processing (105 °C, 60 min) of wastes generated from the industrial processing of turbot, salmon, trout, seabream and seabass. These peptones were included (in the range of 2.6–11 g/L of soluble protein) as main source of organic nitrogen (protein substrates) in low-cost media for the culture of lactic acid bacteria (LAB), marine probiotic bacteria (MPB) and ubiquitous Gram+ bacteria. In most cases, batch fermentations conducted in aquaculture peptone media led to the best growth, metabolic productions and yields. Nevertheless, no significant differences between aquaculture peptones and commercial media were generally observed. Kinetic parameters from a logistic equation and used for cultures modeling were applied with the purpose of comparing the bioproduction outcomes. In economical terms, the validity of the aquaculture peptones as substitutives of the peptones (meat extract, casitone, etc.) from commercial media was also compared. The decreasing of the costs for LAB bioproductions ranged between 3–4 times and the growth costs of MPB and Gram+ bacteria were improved more than 70 and 15 times, respectively, in relation to those found in control commercial media. This research was funded by the projects GAIN (EU, Horizon 2020 Framework Research and Innovation Programme under GA n. 773330) and Xunta de Galicia (Grupos de Potencial Crecimiento, IN607B 2018/19). Peer reviewed